Company Filing History:
1 out of 1 
1 out of 30 
1 out of 3 
Years Active: 2006-2017
Title: Boualem Sendid: Innovator in In Vitro Diagnostics
Introduction
Boualem Sendid is a notable inventor based in Loos, France. He has made significant contributions to the field of in vitro diagnostics, particularly in the diagnosis of invasive fungal infections. With a total of 3 patents to his name, Sendid's work has the potential to impact medical diagnostics and treatment regimens.
Latest Patents
One of his latest patents involves an in vitro method for diagnosing invasive candidiasis (IC) in a subject. This method comprises detecting the presence of aglycan and antibodies directed against specific proteins, including fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma, or serum sample. The invention also relates to determining a suitable treatment regimen for a patient and includes a kit for implementing these methods. Another significant patent focuses on an in vitro diagnostic method for invasive fungal infections using MALDI-TOF mass spectrometry. This method involves analyzing a liquid biological sample from a mammal to detect compounds of interest that indicate the presence of a fungal infection.
Career Highlights
Throughout his career, Boualem Sendid has worked with reputable organizations, including the Centre Hospitalier Regional Universitaire (CHRU) and Bio-Rad Innovations. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.
Collaborations
Sendid has collaborated with notable professionals in his field, including Daniel Poulain and Jacques Esnault. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Boualem Sendid's contributions to in vitro diagnostics demonstrate his commitment to improving medical technology. His innovative methods for diagnosing invasive fungal infections have the potential to enhance patient care and treatment outcomes.